Proteins from volcano plot which had notable increases or decreases listed in order of greatest to least significance (adjusted p-values). by Eiman Y. Ibrahim (10731078)

Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesi... by Jacob P. Rastas (20642173)

Subjects:

Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

Subjects:

S1 File - by Jacob P. Rastas (20642173)

Subjects:

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

Subjects:

AVAcore placement. by Jacob P. Rastas (20642173)

Subjects:

Scores, change in the measures of interest, and <i>p</i>-values for binomial tests of significance in change in scores before and since the pandemic began. by Stacey Giroux (13607651)

Subjects:

Tissue-specific profiling of the photoreceptor nuclear transcriptome reveals significant changes in early and late aging. by Juan Jauregui-Lozano (12024868)

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Population-level determinant changes in aging, population growth, and epidemiological changes for two types of high alcohol use-related Stroke DALYs globally and in various SDI reg... by Nannan Qian (10650782)

Subjects:

Metabolomic analysis of <i>pgl</i> indicates compensatory changes and decreased pyrimidine metabolism. by Jisun Kim (837555)

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

Normalized significant family changes in abundance. by Karley K. Mahalak (3212670)

Perioperative changes in CLSS questionnaire results stratified by uroflowmetry parameter changes. by Yuta Takeshima (818627)

SQFZ reverses constitutive and PI3K pathway-induced cisplatin resistance. by Bin Yan (32980)

Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)